Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT
1 Lung Transplant Unit, University Hospital Gasthuisberg, Leuven, Belgium. Electronic address: geert.verleden@uzleuven.be.
2 St. Vincent's Hospital, Sydney, New South Wales, Australia.
3 Division of Pulmonary, Critical Care, and Sleep Medicine, University of Washington Medical Center, Seattle, Washington, USA.
4 Institute of Transplantation, Freeman Hospital, Newcastle Upon Tyne Hospitals NHS, Foundation Trust and Institute of Cellular Medicine, Newcastle University, Newcastle, UK.
5 Department of Cardiac, Thoracic and Vascular Sciences, Pathological Anatomy Section, University of Padova Medical School, Padova, Italy.
6 Florida Hospital Transplant Institute, Orlando, Florida, USA.
7 Department of Respiratory Medicine, Hannover Medical School, Member of the German Center for Lung Research, Hannover, Germany.
8 Division of Pulmonary & Critical Care, Washington University of St. Louis, St. Louis, Missouri, USA.
9 Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA.
10 Toronto Lung Transplant Program, University Health Network, University of Toronto, Toronto, Ontario, Canada.
11 Department of Cellular Pathology, Queen Elizabeth Hospital, Birmingham, UK.
12 Lung Transplant Service, The Alfred Hospital, Melbourne, Victoria, Australia.
13 Lung Transplant Unit, University Hospital Gasthuisberg, Leuven, Belgium.